26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic)

Journal of Child and Adolescent Psychopharmacology,Volume 32, Issue 8, Page 453-458, October 2022.

Source: Journal of Child and Adolescent Psychopharmacology - October 17, 2022 Category: Pediatrics Authors: Sarah Atkinson Mary Bachinsky Yaron Raiter Paula Abreu Claudia Ianos Phillip Chappell Robert L. Findling Source Type: research